This is thanks to Lilly's dominance in the billion-dollar weight loss drug market. Lilly's Mounjaro and Zepbound have helped ...

Drugmaker Eli Lilly named Lucas Montarce as chief financial officer, filling a vacancy left by the departure of Anat ...

The facility at a business park in Raheen, Limerick, was first announced in 2022 and this is the second time that Lilly has ...

As the company continues to push for GLP-1 market share, it has tapped an internal veteran with recent experience managing research and development finance.

This additional investment is part of the most ambitious manufacturing expansion agenda in the company's history. Since 2020, ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

US pharmaceutical giant Eli Lilly has announced plans for a $1bn (€907m) expansion of its Limerick manufacturing site. This ...

Pharmaceutical company Eli Lilly has announced a further €927 million investment at its facility at Raheen in Limerick, creating a further 150 jobs there.

As a part of this expansion, Lilly will create another 150 jobs for highly skilled workers in Limerick, bringing its total ...

Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

Eli Lilly (NYSE: LLY) offers investors the same ... Positive product news or news about candidates in the pipeline will do that job. Since Lilly is in the early days of its weight loss drug ...